United States Oral Anticoagulant Market Report 2017
In this report, the United States Oral Anticoagulant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
- with sales (volume), revenue (value), market share and growth rate of Oral Anticoagulant in these regions, from 2012 to 2022 (forecast).
- Akers Biosciences
- Pfizer
- Eisai
- AstraZeneca
- Eli Lilly
- Medicure
- GlaxoSmithKline
- Novartis AG
- Sanofi
- Warfarin
- Dabigatran
- Rivaroxaban
- Others
- Thromboembolic Disease
- Disseminated Intravascular Coagulation
- Cardiovascular Surgery
- Others
United States Oral Anticoagulant Market Report 2017
1 ORAL ANTICOAGULANT OVERVIEW
1.1 Product Overview and Scope of Oral Anticoagulant
1.2 Classification of Oral Anticoagulant by Product Category
1.2.1 United States Oral Anticoagulant Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oral Anticoagulant Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Warfarin
1.2.4 Dabigatran
1.2.5 Rivaroxaban
1.2.6 Others
1.3 United States Oral Anticoagulant Market by Application/End Users
1.3.1 United States Oral Anticoagulant Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Thromboembolic Disease
1.3.3 Disseminated Intravascular Coagulation
1.3.4 Cardiovascular Surgery
1.3.5 Others
1.4 United States Oral Anticoagulant Market by Region
1.4.1 United States Oral Anticoagulant Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oral Anticoagulant Status and Prospect (2012-2022)
1.4.3 Southwest Oral Anticoagulant Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oral Anticoagulant Status and Prospect (2012-2022)
1.4.5 New England Oral Anticoagulant Status and Prospect (2012-2022)
1.4.6 The South Oral Anticoagulant Status and Prospect (2012-2022)
1.4.7 The Midwest Oral Anticoagulant Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Anticoagulant (2012-2022)
1.5.1 United States Oral Anticoagulant Sales and Growth Rate (2012-2022)
1.5.2 United States Oral Anticoagulant Revenue and Growth Rate (2012-2022)
2 UNITED STATES ORAL ANTICOAGULANT MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States Oral Anticoagulant Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Anticoagulant Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Anticoagulant Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Anticoagulant Market Competitive Situation and Trends
2.4.1 United States Oral Anticoagulant Market Concentration Rate
2.4.2 United States Oral Anticoagulant Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)
3.1 United States Oral Anticoagulant Sales and Market Share by Region (2012-2017)
3.2 United States Oral Anticoagulant Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Anticoagulant Price by Region (2012-2017)
4 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)
4.1 United States Oral Anticoagulant Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Anticoagulant Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Anticoagulant Price by Type (2012-2017)
4.4 United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)
5 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) BY APPLICATION (2012-2017)
5.1 United States Oral Anticoagulant Sales and Market Share by Application (2012-2017)
5.2 United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 UNITED STATES ORAL ANTICOAGULANT PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Akers Biosciences
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Anticoagulant Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Akers Biosciences Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Oral Anticoagulant Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eisai
6.3.2 Oral Anticoagulant Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eisai Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Oral Anticoagulant Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly
6.5.2 Oral Anticoagulant Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Medicure
6.6.2 Oral Anticoagulant Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Medicure Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
6.7.2 Oral Anticoagulant Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 GlaxoSmithKline Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Novartis AG
6.8.2 Oral Anticoagulant Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis AG Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi
6.9.2 Oral Anticoagulant Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
7 ORAL ANTICOAGULANT MANUFACTURING COST ANALYSIS
7.1 Oral Anticoagulant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Anticoagulant
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oral Anticoagulant Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Anticoagulant Major Manufacturers in 2016
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES ORAL ANTICOAGULANT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)
11.1 United States Oral Anticoagulant Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Anticoagulant Sales Volume Forecast by Region (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 ORAL ANTICOAGULANT OVERVIEW
1.1 Product Overview and Scope of Oral Anticoagulant
1.2 Classification of Oral Anticoagulant by Product Category
1.2.1 United States Oral Anticoagulant Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oral Anticoagulant Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Warfarin
1.2.4 Dabigatran
1.2.5 Rivaroxaban
1.2.6 Others
1.3 United States Oral Anticoagulant Market by Application/End Users
1.3.1 United States Oral Anticoagulant Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Thromboembolic Disease
1.3.3 Disseminated Intravascular Coagulation
1.3.4 Cardiovascular Surgery
1.3.5 Others
1.4 United States Oral Anticoagulant Market by Region
1.4.1 United States Oral Anticoagulant Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oral Anticoagulant Status and Prospect (2012-2022)
1.4.3 Southwest Oral Anticoagulant Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oral Anticoagulant Status and Prospect (2012-2022)
1.4.5 New England Oral Anticoagulant Status and Prospect (2012-2022)
1.4.6 The South Oral Anticoagulant Status and Prospect (2012-2022)
1.4.7 The Midwest Oral Anticoagulant Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Anticoagulant (2012-2022)
1.5.1 United States Oral Anticoagulant Sales and Growth Rate (2012-2022)
1.5.2 United States Oral Anticoagulant Revenue and Growth Rate (2012-2022)
2 UNITED STATES ORAL ANTICOAGULANT MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States Oral Anticoagulant Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Anticoagulant Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Anticoagulant Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Anticoagulant Market Competitive Situation and Trends
2.4.1 United States Oral Anticoagulant Market Concentration Rate
2.4.2 United States Oral Anticoagulant Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)
3.1 United States Oral Anticoagulant Sales and Market Share by Region (2012-2017)
3.2 United States Oral Anticoagulant Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Anticoagulant Price by Region (2012-2017)
4 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)
4.1 United States Oral Anticoagulant Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Anticoagulant Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Anticoagulant Price by Type (2012-2017)
4.4 United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)
5 UNITED STATES ORAL ANTICOAGULANT SALES (VOLUME) BY APPLICATION (2012-2017)
5.1 United States Oral Anticoagulant Sales and Market Share by Application (2012-2017)
5.2 United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 UNITED STATES ORAL ANTICOAGULANT PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Akers Biosciences
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Anticoagulant Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Akers Biosciences Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Oral Anticoagulant Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eisai
6.3.2 Oral Anticoagulant Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eisai Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Oral Anticoagulant Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly
6.5.2 Oral Anticoagulant Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Medicure
6.6.2 Oral Anticoagulant Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Medicure Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
6.7.2 Oral Anticoagulant Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 GlaxoSmithKline Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Novartis AG
6.8.2 Oral Anticoagulant Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis AG Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi
6.9.2 Oral Anticoagulant Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
7 ORAL ANTICOAGULANT MANUFACTURING COST ANALYSIS
7.1 Oral Anticoagulant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Anticoagulant
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oral Anticoagulant Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Anticoagulant Major Manufacturers in 2016
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES ORAL ANTICOAGULANT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)
11.1 United States Oral Anticoagulant Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Anticoagulant Sales Volume Forecast by Region (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Oral Anticoagulant
Figure United States Oral Anticoagulant Market Size (K MT) by Type (2012-2022)
Figure United States Oral Anticoagulant Sales Volume Market Share by Type (Product Category) in 2016
Figure Warfarin Product Picture
Figure Dabigatran Product Picture
Figure Rivaroxaban Product Picture
Figure Others Product Picture
Figure United States Oral Anticoagulant Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Oral Anticoagulant by Application in 2016
Figure Thromboembolic Disease Examples
Table Key Downstream Customer in Thromboembolic Disease
Figure Disseminated Intravascular Coagulation Examples
Table Key Downstream Customer in Disseminated Intravascular Coagulation
Figure Cardiovascular Surgery Examples
Table Key Downstream Customer in Cardiovascular Surgery
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Oral Anticoagulant Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Sales (K MT) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure United States Oral Anticoagulant Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Anticoagulant Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Table United States Market Oral Anticoagulant Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Anticoagulant Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Oral Anticoagulant Market Share of Top 3 Players/Suppliers
Figure United States Oral Anticoagulant Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Anticoagulant Product Category
Table United States Oral Anticoagulant Sales (K MT) by Region (2012-2017)
Table United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Region in 2016
Table United States Oral Anticoagulant Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region in 2016
Table United States Oral Anticoagulant Price (USD/MT) by Region (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) by Type (2012-2017)
Table United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Type in 2016
Table United States Oral Anticoagulant Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type in 2016
Table United States Oral Anticoagulant Price (USD/MT) by Types (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) by Application (2012-2017)
Table United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application in 2016
Table United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Table Akers Biosciences Basic Information List
Table Akers Biosciences Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Pfizer Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eisai Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eisai Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eisai Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eli Lilly Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Medicure Basic Information List
Table Medicure Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Medicure Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Medicure Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Medicure Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Novartis AG Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Sanofi Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulant
Figure Manufacturing Process Analysis of Oral Anticoagulant
Figure Oral Anticoagulant Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulant Major Players/Suppliers in 2016
Table Major Buyers of Oral Anticoagulant
Table Distributors/Traders List
Figure United States Oral Anticoagulant Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Price (USD/MT) Trend Forecast (2017-2022)
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type in 2022
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application in 2022
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Oral Anticoagulant
Figure United States Oral Anticoagulant Market Size (K MT) by Type (2012-2022)
Figure United States Oral Anticoagulant Sales Volume Market Share by Type (Product Category) in 2016
Figure Warfarin Product Picture
Figure Dabigatran Product Picture
Figure Rivaroxaban Product Picture
Figure Others Product Picture
Figure United States Oral Anticoagulant Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Oral Anticoagulant by Application in 2016
Figure Thromboembolic Disease Examples
Table Key Downstream Customer in Thromboembolic Disease
Figure Disseminated Intravascular Coagulation Examples
Table Key Downstream Customer in Disseminated Intravascular Coagulation
Figure Cardiovascular Surgery Examples
Table Key Downstream Customer in Cardiovascular Surgery
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Oral Anticoagulant Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Sales (K MT) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure United States Oral Anticoagulant Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Anticoagulant Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Table United States Market Oral Anticoagulant Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Anticoagulant Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Oral Anticoagulant Market Share of Top 3 Players/Suppliers
Figure United States Oral Anticoagulant Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Anticoagulant Product Category
Table United States Oral Anticoagulant Sales (K MT) by Region (2012-2017)
Table United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Region in 2016
Table United States Oral Anticoagulant Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region in 2016
Table United States Oral Anticoagulant Price (USD/MT) by Region (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) by Type (2012-2017)
Table United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Type in 2016
Table United States Oral Anticoagulant Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type in 2016
Table United States Oral Anticoagulant Price (USD/MT) by Types (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)
Table United States Oral Anticoagulant Sales (K MT) by Application (2012-2017)
Table United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application in 2016
Table United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Table Akers Biosciences Basic Information List
Table Akers Biosciences Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Pfizer Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eisai Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eisai Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eisai Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eli Lilly Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Medicure Basic Information List
Table Medicure Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Medicure Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Medicure Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Medicure Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Novartis AG Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Anticoagulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Sanofi Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulant
Figure Manufacturing Process Analysis of Oral Anticoagulant
Figure Oral Anticoagulant Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulant Major Players/Suppliers in 2016
Table Major Buyers of Oral Anticoagulant
Table Distributors/Traders List
Figure United States Oral Anticoagulant Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Price (USD/MT) Trend Forecast (2017-2022)
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Type in 2022
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume (K MT) Forecast by Application in 2022
Table United States Oral Anticoagulant Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources